FGFR2 and Hepatic fibrosis: With the aim of discovering a therapeutic agent to inhibit FGFR2 and mitigate liver fibrosis, high-throughput affinity screening based on surface plasmon resonance (SPR) sensor chips were carried out with a natural compound library.